Wen Xue to Cholangiocarcinoma
This is a "connection" page, showing publications Wen Xue has written about Cholangiocarcinoma.
Connection Strength
1.533
-
Qiao Y, Yee MF, Parikh CN, Ma B, Cao Y, Shih YH, Wu JQ, Ruscetti M, Liang SQ, Xue W. KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression. Adv Sci (Weinh). 2026 Jan; 13(6):e11312.
Score: 0.940
-
Mou H, Ozata DM, Smith JL, Sheel A, Kwan SY, Hough S, Kucukural A, Kennedy Z, Cao Y, Xue W. CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling. Genome Med. 2019 04 16; 11(1):21.
Score: 0.593